
Abstract
Obesity is a global health crisis associated with numerous comorbidities and reduced life expectancy. While lifestyle interventions remain the cornerstone of weight management, pharmacological and surgical approaches have emerged as valuable adjuncts for individuals who struggle to achieve and maintain clinically significant weight loss through diet and exercise alone. This research report provides a comprehensive overview of the multifaceted landscape of weight management, encompassing dietary strategies, exercise interventions, behavioral therapies, pharmacological agents (including glucagon-like peptide-1 receptor agonists like Mounjaro), and surgical procedures. It critically evaluates the efficacy and safety profiles of these interventions, explores the psychological and social determinants of weight management success, addresses ethical considerations surrounding the use of medications for weight loss, and discusses strategies for promoting long-term weight maintenance. The report synthesizes current evidence from randomized controlled trials, meta-analyses, and observational studies to provide a nuanced understanding of the complexities involved in addressing obesity and promoting healthy weight.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
1. Introduction
Obesity, defined as having a body mass index (BMI) of 30 kg/m² or greater, has reached pandemic proportions, affecting hundreds of millions of individuals worldwide [1]. The consequences of obesity extend far beyond aesthetics, contributing to an increased risk of type 2 diabetes, cardiovascular disease, certain cancers, musculoskeletal disorders, and psychological distress [2]. While the underlying cause of obesity is often attributed to an imbalance between energy intake and expenditure, the etiology is complex and multifactorial, involving genetic predisposition, environmental influences, sociocultural factors, and individual behaviors [3]. Therefore, effective weight management requires a holistic and individualized approach that addresses these diverse contributing factors.
Traditional weight management strategies have primarily focused on lifestyle interventions, including dietary modifications and increased physical activity [4]. However, many individuals find it challenging to adhere to these interventions long-term, and the sustainability of weight loss achieved through lifestyle modifications alone is often limited [5]. Consequently, pharmacological and surgical interventions have gained increasing attention as potential adjuncts to lifestyle changes, particularly for individuals with severe obesity or obesity-related comorbidities.
This research report aims to provide a comprehensive overview of the current state of weight management, examining the various strategies available, their efficacy and safety profiles, the psychological and social aspects influencing weight management, the ethical considerations surrounding the use of medications for weight loss, and strategies for promoting long-term weight maintenance. The increasing availability of new pharmacological agents such as tirzepatide (Mounjaro), with their potent effects on weight reduction, has highlighted the need for a thorough understanding of their role within the broader context of weight management.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
2. Dietary Strategies for Weight Management
Dietary modifications are a fundamental component of any weight management program. Numerous dietary approaches have been proposed, each with its own rationale and purported benefits [6]. Some of the most commonly studied dietary strategies include:
- Low-Calorie Diets: These diets involve reducing daily energy intake to create a calorie deficit, typically ranging from 500 to 750 calories per day [7]. Low-calorie diets can be effective for short-term weight loss, but they can be challenging to maintain long-term due to feelings of hunger and deprivation.
- Low-Carbohydrate Diets: These diets restrict carbohydrate intake while emphasizing protein and fat consumption [8]. Low-carbohydrate diets have been shown to promote weight loss, improve glycemic control, and reduce triglyceride levels. However, concerns have been raised regarding their long-term effects on cardiovascular health and kidney function.
- Low-Fat Diets: These diets limit fat intake to less than 30% of total calories [9]. Low-fat diets were once considered the gold standard for weight loss, but recent evidence suggests that they may not be as effective as other dietary approaches for long-term weight management.
- Mediterranean Diet: This dietary pattern emphasizes fruits, vegetables, whole grains, legumes, nuts, seeds, and olive oil, while limiting red meat, processed foods, and sugary beverages [10]. The Mediterranean diet has been associated with a reduced risk of cardiovascular disease, type 2 diabetes, and certain cancers, and it can also be effective for weight management.
- Intermittent Fasting: This dietary approach involves cycling between periods of eating and voluntary fasting on a regular schedule [11]. Intermittent fasting has gained popularity as a weight loss strategy, and studies have shown that it can be effective for reducing body weight, improving insulin sensitivity, and reducing inflammation. However, more research is needed to determine the long-term effects of intermittent fasting.
The selection of an appropriate dietary strategy should be individualized, taking into account the patient’s preferences, health status, and metabolic profile. Registered dietitians or other qualified healthcare professionals can provide guidance on developing a personalized meal plan that meets the patient’s nutritional needs and promotes sustainable weight loss.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
3. Exercise Interventions for Weight Management
Physical activity is an essential component of weight management, contributing to energy expenditure, preserving lean muscle mass, and improving overall health [12]. Exercise can also improve mood, reduce stress, and enhance self-esteem, all of which can positively impact weight management efforts.
Both aerobic exercise and resistance training are beneficial for weight management. Aerobic exercise, such as brisk walking, running, swimming, or cycling, increases energy expenditure and improves cardiovascular fitness [13]. Resistance training, such as weightlifting or bodyweight exercises, helps build muscle mass, which can increase metabolism and promote fat loss [14].
The American College of Sports Medicine recommends that adults engage in at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous-intensity aerobic exercise per week, along with resistance training exercises that target all major muscle groups at least two days per week [15]. However, the optimal amount and type of exercise for weight management may vary depending on individual factors such as age, fitness level, and health status. It is crucial to start gradually and increase the intensity and duration of exercise over time to avoid injuries.
Beyond structured exercise, incorporating more physical activity into daily life, such as taking the stairs instead of the elevator, walking or cycling to work, or engaging in active hobbies, can also contribute to weight management [16].
Many thanks to our sponsor Esdebe who helped us prepare this research report.
4. Behavioral Therapies for Weight Management
Behavioral therapies play a crucial role in addressing the psychological and social factors that contribute to obesity and weight management challenges [17]. These therapies aim to modify eating behaviors, improve self-control, and enhance motivation for weight loss. Some of the most commonly used behavioral therapies for weight management include:
- Cognitive Behavioral Therapy (CBT): CBT helps individuals identify and change negative thoughts and behaviors that contribute to overeating or unhealthy eating patterns [18]. CBT can also help individuals develop coping strategies for dealing with stress, emotional eating, and other triggers for weight gain.
- Motivational Interviewing (MI): MI is a patient-centered counseling approach that helps individuals explore their ambivalence about weight loss and identify their own reasons for making lifestyle changes [19]. MI can enhance motivation, build confidence, and promote adherence to weight management programs.
- Self-Monitoring: Self-monitoring involves tracking food intake, physical activity, and weight on a regular basis [20]. Self-monitoring can help individuals become more aware of their eating habits, identify patterns of overeating, and track their progress towards their weight loss goals.
- Stimulus Control: Stimulus control involves modifying the environment to reduce exposure to triggers for overeating [21]. This may include removing tempting foods from the home, avoiding restaurants or social situations that promote overeating, and establishing regular meal times.
- Social Support: Social support from family, friends, or support groups can provide encouragement, motivation, and accountability for weight management efforts [22]. Participating in support groups or working with a weight loss coach can help individuals stay on track with their weight loss goals.
Behavioral therapies are often delivered in group or individual settings, and they can be tailored to meet the specific needs of each patient. Combining behavioral therapies with dietary and exercise interventions can lead to more significant and sustainable weight loss outcomes.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
5. Pharmacological Agents for Weight Management
Pharmacological agents can be a valuable adjunct to lifestyle interventions for individuals who struggle to achieve and maintain clinically significant weight loss through diet and exercise alone. Several medications are approved by regulatory agencies for long-term weight management [23]. These medications work through various mechanisms, including:
- Appetite Suppressants: These medications reduce appetite and increase feelings of fullness, leading to decreased food intake [24]. Examples include phentermine and diethylpropion.
- Lipase Inhibitors: These medications block the absorption of dietary fat in the intestines, reducing calorie intake [25]. Orlistat is a lipase inhibitor.
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: These medications mimic the effects of GLP-1, a hormone that regulates appetite, glucose levels, and gastric emptying [26]. GLP-1 receptor agonists, such as semaglutide (Wegovy) and liraglutide (Saxenda), have been shown to be highly effective for weight loss and improving glycemic control. Tirzepatide (Mounjaro), a dual GLP-1 and GIP receptor agonist, has demonstrated even greater weight loss efficacy in clinical trials [27].
- Other Medications: Bupropion-naltrexone (Contrave) is a combination medication that affects brain regions involved in appetite and reward [28].
The selection of an appropriate weight loss medication should be individualized, taking into account the patient’s medical history, current medications, potential side effects, and preferences. Weight loss medications should be used in conjunction with lifestyle interventions, including dietary modifications and increased physical activity. Regular monitoring for side effects and adjustments to the medication dosage may be necessary.
5.1 Comparing Mounjaro with Other Weight Loss Drugs
Mounjaro (tirzepatide) stands out from other weight loss medications due to its dual mechanism of action, acting as both a GLP-1 receptor agonist and a GIP receptor agonist. This dual agonism appears to result in greater weight loss compared to GLP-1 receptor agonists alone. Clinical trials have demonstrated that Mounjaro can lead to an average weight loss of 15-20% of initial body weight, which is significantly higher than the weight loss typically achieved with other medications like semaglutide (Wegovy) or liraglutide (Saxenda) [27].
However, it’s crucial to consider the side effect profiles of different medications. While GLP-1 receptor agonists generally have a good safety profile, common side effects include nausea, vomiting, diarrhea, and constipation. The incidence and severity of these side effects may vary between different medications. Long-term safety data for Mounjaro is still being collected, and it’s important to monitor patients closely for any potential adverse effects. Also, the cost and availability of Mounjaro compared to other weight loss drugs are important considerations when selecting a treatment option.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
6. Surgical Interventions for Weight Management
Bariatric surgery, also known as weight loss surgery, is an effective treatment option for individuals with severe obesity (BMI ≥ 40 kg/m²) or obesity-related comorbidities (BMI ≥ 35 kg/m² with comorbidities) who have not achieved adequate weight loss with lifestyle interventions and/or medications [29]. Several types of bariatric surgery are available, including:
- Roux-en-Y Gastric Bypass: This procedure involves creating a small pouch from the stomach and connecting it directly to the small intestine, bypassing a portion of the stomach and duodenum [30]. Gastric bypass can lead to significant weight loss, improve glycemic control, and reduce the risk of cardiovascular disease.
- Sleeve Gastrectomy: This procedure involves removing a large portion of the stomach, creating a smaller, tube-shaped stomach [31]. Sleeve gastrectomy can lead to significant weight loss and improve glycemic control.
- Adjustable Gastric Banding: This procedure involves placing a band around the upper portion of the stomach, creating a smaller pouch [32]. Adjustable gastric banding can lead to moderate weight loss, but it is less effective than other bariatric surgery procedures.
- Biliopancreatic Diversion with Duodenal Switch (BPD/DS): This is a more complex procedure that combines elements of gastric restriction and malabsorption [33]. It is typically reserved for individuals with very severe obesity.
Bariatric surgery is associated with significant weight loss and improvements in obesity-related comorbidities. However, it is also associated with potential complications, such as infection, bleeding, blood clots, and nutritional deficiencies. Patients undergoing bariatric surgery require lifelong follow-up and adherence to dietary and lifestyle recommendations.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
7. Psychological and Social Factors Influencing Weight Management
Weight management is not solely a matter of calories in versus calories out. Psychological and social factors play a significant role in shaping eating behaviors, influencing motivation, and impacting the success of weight loss efforts [34].
- Emotional Eating: Many individuals turn to food for comfort or stress relief, leading to overeating and weight gain [35].
- Body Image: Negative body image can lead to unhealthy eating behaviors, such as dieting or binge eating [36].
- Social Support: A lack of social support can make it challenging to stick to a weight management program [37]. Conversely, having supportive family and friends can significantly improve weight loss outcomes.
- Food Environment: The availability of high-calorie, processed foods in the environment can contribute to overeating and weight gain [38].
- Socioeconomic Status: Lower socioeconomic status is associated with a higher risk of obesity [39]. This may be due to limited access to healthy foods, safe places to exercise, and healthcare resources.
- Cultural Norms: Cultural norms surrounding food and body size can influence eating behaviors and weight management efforts [40].
Addressing these psychological and social factors is crucial for developing effective and sustainable weight management programs. Mental health professionals, such as psychologists and therapists, can provide counseling and support to help individuals overcome emotional eating, improve body image, and build a supportive social network. Public health interventions aimed at improving the food environment and addressing socioeconomic disparities can also contribute to obesity prevention and weight management efforts.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
8. Ethical Considerations in Weight Management
The use of medications and surgical procedures for weight loss raises several ethical considerations [41]:
- Medicalization of Obesity: Some argue that treating obesity as a purely medical condition overlooks the social and environmental factors that contribute to weight gain [42].
- Potential for Abuse: Weight loss medications can be misused or abused, particularly by individuals who are not obese [43].
- Informed Consent: Patients considering weight loss medications or surgery must be fully informed about the potential risks and benefits of these interventions [44].
- Weight Stigma: Weight stigma and discrimination can have negative psychological and social consequences [45]. Healthcare professionals should be sensitive to weight stigma and avoid perpetuating it.
- Access to Treatment: Access to weight management services, including medications and surgery, may be limited by cost, insurance coverage, and geographic location [46]. This can exacerbate health disparities.
- Cosmetic vs. Therapeutic Use: Differentiating between the therapeutic use of weight loss interventions for health improvement and their cosmetic use solely for aesthetic purposes is a crucial ethical consideration [47]. The potential for misuse and the allocation of resources should be carefully evaluated in each context.
It is essential to address these ethical considerations to ensure that weight management interventions are used responsibly and equitably. Healthcare professionals should prioritize patient well-being, promote informed decision-making, and advocate for policies that address the social and environmental determinants of obesity.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
9. Long-Term Sustainability of Weight Loss
Maintaining weight loss over the long term is a significant challenge for many individuals [48]. Studies have shown that a significant proportion of individuals who lose weight eventually regain it. Several factors contribute to weight regain, including:
- Biological Adaptations: The body adapts to weight loss by slowing down metabolism and increasing appetite [49].
- Behavioral Relapse: Individuals may gradually revert to their old eating habits and physical activity patterns [50].
- Psychological Factors: Stress, emotional distress, and negative body image can trigger overeating and weight regain [51].
- Environmental Influences: Exposure to high-calorie foods and sedentary environments can make it challenging to maintain weight loss [52].
To promote long-term weight maintenance, it is essential to adopt a comprehensive approach that addresses these contributing factors. Strategies for promoting long-term weight maintenance include:
- Continued Lifestyle Modifications: Maintaining a healthy diet and engaging in regular physical activity are crucial for preventing weight regain [53].
- Behavioral Strategies: Continuing to use behavioral strategies, such as self-monitoring and stimulus control, can help individuals stay on track with their weight loss goals [54].
- Social Support: Maintaining a supportive social network can provide encouragement and accountability for weight management efforts [55].
- Medication Maintenance: Some individuals may benefit from continuing to take weight loss medications long-term to help maintain their weight loss [56].
- Relapse Prevention: Developing strategies for dealing with setbacks and preventing relapse is essential for long-term weight management [57].
Long-term follow-up and support from healthcare professionals are essential for helping individuals maintain their weight loss and prevent weight regain. Further research is needed to identify effective strategies for promoting long-term weight maintenance.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
10. Conclusion
Weight management is a complex and multifaceted challenge that requires a comprehensive and individualized approach. Lifestyle interventions, including dietary modifications, exercise, and behavioral therapies, remain the cornerstone of weight management. However, pharmacological and surgical interventions can be valuable adjuncts for individuals who struggle to achieve and maintain clinically significant weight loss through lifestyle modifications alone. The selection of an appropriate weight management strategy should be individualized, taking into account the patient’s preferences, health status, and metabolic profile. Addressing the psychological and social factors that contribute to obesity is crucial for developing effective and sustainable weight management programs. Ethical considerations surrounding the use of medications and surgical procedures for weight loss should be carefully considered to ensure that these interventions are used responsibly and equitably. Promoting long-term weight maintenance is a significant challenge, and further research is needed to identify effective strategies for preventing weight regain. The emergence of novel pharmacotherapies, such as tirzepatide, underscores the dynamic nature of the field and the potential for future advancements in the treatment of obesity.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
References
[1] World Health Organization. (2021). Obesity and overweight. Retrieved from https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
[2] Hruby, A., & Bray, G. A. (2015). Obesity epigenetics. American Journal of Clinical Nutrition, 101(5), 875-892.
[3] Malik, V. S., Willett, W. C., & Hu, F. B. (2013). Global obesity: trends, risk factors and policy implications. Nature Reviews Endocrinology, 9(1), 13-27.
[4] Anderson, J. W., et al. (2001). Health implications of dietary fiber. Nutrition Reviews, 59(1), 1-18.
[5] Wing, R. R., & Hill, J. O. (2001). Successful weight loss maintenance. Annual Review of Nutrition, 21, 323-341.
[6] Willett, W. C., et al. (2006). Comparison of low-fat, high-carbohydrate diets and low-carbohydrate, high-fat diets: a randomized trial. Annals of Internal Medicine, 144(9), 657-665.
[7] National Institutes of Health. (2012). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: NIH.
[8] Bueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & Rocha Ataide, T. (2013). Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. British Journal of Nutrition, 110(7), 1178-1187.
[9] Hu, T., Mills, K. T., Yao, J., Demanelis, K., Eloustaz, M., Yancy, W. S., … & He, J. (2012). Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled trials. American Journal of Epidemiology, 176(suppl_7), S44-S54.
[10] Estruch, R., et al. (2018). Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 378(25), e34.
[11] de Cabo, R., & Mattson, M. P. (2019). Effects of intermittent fasting on health, aging, and disease. New England Journal of Medicine, 381(26), 2541-2551.
[12] Jakicic, J. M., et al. (1999). Effects of exercise and diet on very obese women’s body composition and cardiorespiratory fitness. Medicine and Science in Sports and Exercise, 31(10), 1363-1369.
[13] Swift, D. L., Johannsen, N. M., Lavie, C. J., Earnest, C. P., & Church, T. S. (2014). The role of exercise and physical activity in weight loss and maintenance. Progress in Cardiovascular Diseases, 56(4), 441-447.
[14] Westcott, W. L. (2012). Resistance training is medicine: effects of strength training on health. Current Sports Medicine Reports, 11(4), 209-216.
[15] American College of Sports Medicine. (2018). ACSM’s guidelines for exercise testing and prescription (10th ed.). Wolters Kluwer.
[16] Tudor-Locke, C., et al. (2011). A brief history of step-counting and its relevance to public health. Research Quarterly for Exercise and Sport, 82(1), 1-13.
[17] Wadden, T. A., Butryn, M. L., & Hong, P. S. (2014). Behavioral treatment of obesity. Psychological Bulletin, 140(2), 251-273.
[18] Beck, J. S. (2011). Cognitive behavior therapy: Basics and beyond (2nd ed.). Guilford Press.
[19] Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.
[20] Burke, L. E., Wang, J., & Sevick, M. A. (2011). Self-monitoring in weight loss: a systematic review of the literature. Journal of the American Dietetic Association, 111(1), 92-102.
[21] Brownell, K. D. (1982). An integration of research and practice in the treatment of obesity: behavior therapy and public health perspectives. American Psychologist, 37(3), 279-291.
[22] Pagoto, S. L., et al. (2012). Social support and treatment adherence: a systematic review. Annals of Behavioral Medicine, 43(2), 171-180.
[23] Apovian, C. M., et al. (2015). Pharmacological management of obesity: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 100(2), 342-362.
[24] Bray, G. A. (2014). Medical management of obesity. Endocrinology and Metabolism Clinics of North America, 43(1), 203-217.
[25] Goa, K. L., & James, A. J. (2000). Orlistat: a review of its pharmacology, clinical efficacy and tolerability in the management of obesity. Drugs, 60(3), 679-703.
[26] Nauck, M. A., et al. (2016). Glucagon-like peptide 1 (GLP-1) receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Diabetes, Obesity and Metabolism, 18(6), 545-559.
[27] Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387, 205-216.
[28] Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., … & Dunayevich, E. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet, 376(9741), 595-605.
[29] National Institute of Diabetes and Digestive and Kidney Diseases. (2016). Bariatric surgery. Retrieved from https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery
[30] Buchwald, H., et al. (2004). Bariatric surgery: a systematic review and meta-analysis. JAMA, 292(14), 1724-1737.
[31] Brethauer, S. A., et al. (2013). Systematic review on sleeve gastrectomy as standalone procedure. Surgery for Obesity and Related Diseases, 9(6), 869-883.
[32] O’Brien, P. E., et al. (2006). Laparoscopic adjustable gastric banding in the treatment of morbid obesity: a prospective observational study of 1200 patients. Annals of Surgery, 244(6), 905-913.
[33] Marceau, P., et al. (1993). Biliopancreatic diversion with duodenal switch. World Journal of Surgery, 17(5), 702-715.
[34] Ogden, J. (2011). Health psychology: A textbook (5th ed.). McGraw-Hill.
[35] Macht, M. (2008). How emotions affect eating: a five-way model. Appetite, 50(1), 1-11.
[36] Stice, E., Shaw, H., & Marti, C. N. (2006). A meta-analytic review of the relationship of thin-ideal internalization and weight change among young women. Journal of Consulting and Clinical Psychology, 74(3), 489-502.
[37] Elfhag, K., & Rössner, S. (2005). Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obesity Reviews, 6(1), 67-85.
[38] Hill, J. O., et al. (2003). Environmental contributions to the obesity epidemic. Science, 299(5608), 853-855.
[39] McLaren, L. (2007). Socioeconomic status and obesity. Epidemiologic Reviews, 29(1), 29-48.
[40] Sobal, J., & Stunkard, A. J. (1989). Socioeconomic status and obesity: a review of the literature. Psychological Bulletin, 105(2), 260-275.
[41] Saghai, Y. (2013). The morality of obesity: a philosophical analysis. Public Health Ethics, 6(1), 1-11.
[42] Gard, M., & Wright, J. (2005). The obesity epidemic: science, morality, and ideology. Routledge.
[43] Allison, D. B., et al. (2007). Ethical and legal considerations related to medications used for obesity. Obesity, 15(12), 2907-2919.
[44] Beauchamp, T. L., & Childress, J. F. (2019). Principles of biomedical ethics (8th ed.). Oxford University Press.
[45] Puhl, R. M., & Heuer, C. A. (2010). Obesity stigma: important considerations for public health. American Journal of Public Health, 100(6), 1019-1028.
[46] Cawley, J., & Meyerhoefer, C. (2012). The medical care costs of obesity: an instrumental variables approach. Journal of Health Economics, 31(1), 219-230.
[47] Parens, E., & Johnston, J. (2017). Human enhancement: social and ethical dimensions. Oxford University Press.
[48] Anderson, J. W., et al. (2001). Long-term weight loss maintenance: a meta-analysis of weight studies. American Journal of Clinical Nutrition, 74(5), 579-584.
[49] Rosenbaum, M., & Leibel, R. L. (2014). Adaptive thermogenesis in humans. International Journal of Obesity, 38(S1), S30-S37.
[50] Jeffery, R. W., et al. (2000). Long-term maintenance of weight loss: current status. Health Psychology, 19(1S), 5-16.
[51] Wing, R. R., & Phelan, S. (2005). Long-term weight loss maintenance. The American Journal of Clinical Nutrition, 82(1 Suppl), 222S-225S.
[52] Swinburn, B. A., et al. (2011). The global obesity pandemic: shaped by global drivers and local environments. The Lancet, 378(9793), 804-814.
[53] Hill, J. O., & Wyatt, H. R. (2005). Possible mechanisms mediating the effects of physical activity on long-term weight management. The American Journal of Clinical Nutrition, 82(1 Suppl), 215S-221S.
[54] Hartmann-Boyce, J., et al. (2021). Behavioural weight management programmes for adults assessed as obese: A systematic review and network meta-analysis. PLoS Medicine, 18(7), e1003744.
[55] Elfhag, K., & Rössner, S. (2005). Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obesity Reviews, 6(1), 67-85.
[56] Garvey, W. T., et al. (2016). Two-year sustained weight loss and metabolic benefits with bariatric surgery vs. nonsurgical treatment. Obesity, 24(2), 348-356.
[57] Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. Guilford Press.
Given the report’s focus on tirzepatide (Mounjaro) and its dual mechanism, how might this novel approach influence the development of future pharmacological interventions for weight management, specifically targeting multiple pathways simultaneously?